CAPITOLIS LIQUID GLOBAL MARKETS LLC
Position in GPCR — Structure Therapeutics Inc.
CIK 2094379
NEW YORK, NY
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$55,492,660
New position
Shares Held
1,151,300
first reported quarter
Ownership
0.540%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITOLIS LIQUID GLOBAL MARKETS LLC holds $347,567,452 across 10 Biotechnology names. GPCR ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
1,975,800 | $104,164,176 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
75,000 | $57,948,000 | |
| 3 | GPCR |
Structure Therapeutics Inc.
This page
|
1,151,300 | $55,492,660 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,013,500 | $40,773,105 | |
| 5 | CELC |
Celcuity Inc.
|
316,500 | $36,125,310 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
725,000 | $20,082,500 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
500,000 | $11,780,000 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
125,000 | $8,403,750 |
All Filings in GPCR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,492,660 | 1,151,300 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||